ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 120 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $392,000 | -38.4% | 205,100 | +49.6% | 0.01% | -47.1% |
| Q2 2015 | $636,000 | -12.6% | 137,100 | -17.7% | 0.02% | -5.6% |
| Q1 2015 | $728,000 | +85.2% | 166,500 | +46.8% | 0.02% | -53.8% |
| Q4 2014 | $393,000 | -17.3% | 113,400 | 0.0% | 0.04% | +225.0% |
| Q3 2014 | $475,000 | +19.9% | 113,400 | +68.0% | 0.01% | +9.1% |
| Q2 2014 | $396,000 | -51.0% | 67,500 | -47.4% | 0.01% | -42.1% |
| Q1 2014 | $808,000 | – | 128,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $5,085,000 | 1.68% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,369,066 | $25,603,000 | 1.03% |
| Lyons Wealth Management, LLC. | 56,775 | $334,000 | 0.30% |
| Callan Capital, LLC | 66,118 | $387,000 | 0.10% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 383,050 | $2,245,000 | 0.06% |
| FCG ADVISORS, LLC | 10,600 | $62,000 | 0.05% |
| OppenheimerFunds, Inc. | 7,000,000 | $41,020,000 | 0.04% |
| NEXT Financial Group, Inc | 19,704 | $86,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 27,893,387 | $163,455,000 | 0.04% |
| MURPHY CAPITAL MANAGEMENT INC | 45,000 | $263,000 | 0.04% |